{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:42:43Z","timestamp":1795023763324,"version":"4.10.2"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Shexiang Baoxin Pill (SBP) is one of the most commonly used traditional Chinese patent medicines for cardiovascular diseases. This systematic review was designed to provide rigorous therapeutic efficacy and safety evidence on the use of SBP combined with trimetazidine in elderly patients with heart failure (HF) secondary to ischaemic cardiomyopathy (ICM).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Relevant randomized controlled trials (RCTs) investigating the clinical efficacy of SBP combined with trimetazidine in treating ICM-associated HF were widely searched in electronic databases, including PubMed, Cochrane library, EMBASE, CBM, CNKI, VMIS, and Wanfang up to January 1, 2018. The methodological quality of each trial was assessed according to the Cochrane Reviewers\u2019 Handbook 5.0. Meta-analysis was performed by using Review Manager 5.3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eighteen RCTs (N\u200a=\u200a1532) that met the criteria were included in the review for the assessment of methodological quality. Meta-analysis showed that, when compared with conventional therapy, SBP combined with trimetazidine significantly improved the clinical efficacy and indices of cardiac function (including increasing left ventricular ejection fraction [LVEF] and 6-minute walk distance [6-MWD], decreasing left ventricular end-diastolic diameter [LVEDD] and left ventricular end-systolic diameter [LVESD]) without serious adverse reactions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This work provides evidence of the benefit of SBP combined with trimetazidine for the treatment of HF secondary to ICM. More high quality and well-designed RCTs are needed to confirm these findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013580","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T03:16:34Z","timestamp":1545275794000},"page":"e13580","source":"Crossref","is-referenced-by-count":19,"title":["Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy"],"prefix":"10.1097","volume":"97","author":[{"given":"Jianxia","family":"Wen","sequence":"first","affiliation":[{"name":"College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu"},{"name":"Department of Pharmacy, 302 Military Hospital of People's Liberation Army, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Zhejiang University of Chinese Medicine, Zhejiang, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Lu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu"},{"name":"Department of Pharmacy, 302 Military Hospital of People's Liberation Army, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Yang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu"},{"name":"Department of Pharmacy, 302 Military Hospital of People's Liberation Army, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, 302 Military Hospital of People's Liberation Army, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7793\/jcoron.19.13-00003","article-title":"Strategy of treatment for ischemic cardiomyopathy","volume":"19","author":"Isomura","year":"2013","journal-title":"J Jpn Coron Assoc"},{"key":"R2-20230914","first-page":"e28","article-title":"American Heart Association Statistics Committee Stroke Statistics Subcommittee Heart disease and stroke statistics-2014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ejhf.130","article-title":"Persistent angina pectoris in ischemic cardiomyopathy: increased rehospitalization and major adverse cardiac events","volume":"16","author":"Mentz","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"R4-20230914","first-page":"269","article-title":"Whole medical systems in lung health and sleep: Focus on Traditional Chinese Medicine","volume":"4","author":"Li","year":"2011","journal-title":"Integrat Therap Lung Health Sleep"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fphar.2018.00137","article-title":"Shexiang Baoxin Pill corrects metabolic disorders in a rat model of metabolic syndrome by targeting mitochondria","volume":"9","author":"Wei","year":"2018","journal-title":"Front Pharmacol"},{"key":"R6-20230914","first-page":"122","article-title":"A Meta-analysis of effectiveness evaluation between Shexiang Baoxin Pill and isosorbide mononitrate tablet","volume":"7","author":"Tan","year":"2017","journal-title":"J Pharm Biomed Sci"},{"key":"R7-20230914","first-page":"1409","article-title":"Advance in modern studies on Shexiang Baoxin Pill","volume":"47","author":"Liu","year":"2016","journal-title":"Chin Tradit Herbs Drug"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"43632","DOI":"10.1038\/srep43632","article-title":"A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases","volume":"7","author":"Fang","year":"2017","journal-title":"Sci Rep"},{"key":"R9-20230914","first-page":"28","article-title":"Effect of shexiang baoxin pill on myocardial fibrosis of diabetic rats","volume":"28","author":"Liu","year":"2012","journal-title":"Pharmacol Clin Chin Materia Medica"},{"key":"R10-20230914","first-page":"546","article-title":"The Influence of shexingbaoxinwan pill on myocardial fibrosis in spontaneously hypertensive rats","volume":"6","author":"Zhang","year":"2008","journal-title":"Chin J Integrat Med Cardio-\/Cerebrovasc Dis"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12325-009-0024-7","article-title":"Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy","volume":"26","author":"Marazzi","year":"2009","journal-title":"Advanc Ther"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fphar.2017.00404","article-title":"Shexiang Baoxin Pills for coronary heart disease in animal models: preclinical evidence and promoting angiogenesis mechanism","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Pharmacol"},{"key":"R13-20230914","first-page":"1162","article-title":"Clinical efficacy of Shexiang Baoxin Wan combining trimetazidine in treatment of ischemic cardiomyopathy and heart failure in elderly patients: a meta-analysis","volume":"10","author":"Lin","year":"2016","journal-title":"Chin J Evid Cardiovasc Med"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1089\/acm.2017.0142","article-title":"Acupoint massage for managing cognitive alterations in older adults: a systematic review and meta-analysis","volume":"24","author":"Liu","year":"2018","journal-title":"J Altern Complement Med"},{"key":"R16-20230914","first-page":"2034","article-title":"Observation on the therapeutic effect of Shexiang Baoxin Pill combined with trimetazidine on senile ischemic cardiomyopathy with Heart Failure","volume":"13","author":"He","year":"2010","journal-title":"Chin Gen Pract"},{"key":"R17-20230914","first-page":"24","article-title":"Clinical effect of Shexiang Baoxin Pill combined with trimetazidine on senile Ischemic cardiomyopathy heart failure","volume":"31","author":"Song","year":"2012","journal-title":"Nei Mongol J Trad Chin Med"},{"key":"R18-20230914","first-page":"288","article-title":"Clinical effect of Shexiang Baoxin Pill combined with trimetazidine on senile ischemic cardiomyopathy heart failure","volume":"11","author":"Chen","year":"2013","journal-title":"Guide China Med"},{"key":"R19-20230914","first-page":"123","article-title":"Clinical effect of Shexiang Baoxin Pill combined with trimetazidine on senile ischemic cardiomyopathy heart failure","volume":"7","author":"Dong","year":"2013","journal-title":"Chin J Mod Drug Appl"},{"key":"R20-20230914","first-page":"161","article-title":"Observation on the therapeutic effect of Shexiang Baoxin Pill combined with trimetazidine on senile ischemic cardiomyopathy with heart failure","volume":"10","author":"Wen","year":"2013","journal-title":"Med Innov China"},{"key":"R21-20230914","first-page":"67","article-title":"Clinical effect and safety of Shexiang Baoxin Pill combined with trimetazidine in treating senile ischemic cardiomyopathy heart failure","volume":"10","author":"Yan","year":"2013","journal-title":"China Health Ind"},{"key":"R22-20230914","first-page":"5330","article-title":"Clinical observation of Shexiang Baoxin Pills combined with trimetazidine in treating senile ischemic cardiomyopathy with heart failure","volume":"25","author":"Huang","year":"2014","journal-title":"Mod Diagn Treat"},{"key":"R23-20230914","first-page":"49","article-title":"Curative observation of using Shexiang Baoxin Pill combined with trimetazidine dihydrochloride to treat elderly patients with ischemic cardiomyopathy and heart failure","volume":"33","author":"He","year":"2015","journal-title":"J Sichuan Trad Chin Med"},{"key":"R24-20230914","first-page":"106","article-title":"Clinical effect and safety of Shexiang Baoxin Pill combined with trimetazidine in treating senile ischemic cardiomyopathy heart failure","volume":"27","author":"Shen","year":"2015","journal-title":"Strait Pharma J"},{"key":"R25-20230914","first-page":"5524","article-title":"Observation on the therapeutic effect of Shexiang Baoxin Pill combined with trimetazidine on senile ischemic cardiomyopathy with heart failure","volume":"2","author":"Wang","year":"2015","journal-title":"J Clin Med"},{"key":"R26-20230914","first-page":"84","article-title":"Clinical observation on 60 cases of senile ischemic cardiomyopathy heart failure treated by Shexiang Baoxin Pill combined with trimetazidine","volume":"24","author":"Zeng","year":"2015","journal-title":"Chin J Ethnomed Ethnopharm"},{"key":"R27-20230914","first-page":"132","article-title":"Clinical analysis of Shexiang Baoxin Pills combined with trimetazidine in treating senile ischemic cardiomyopathy with heart failure","volume":"16","author":"Deng","year":"2016","journal-title":"World Latest Med Inform"},{"key":"R28-20230914","first-page":"88","article-title":"Impact of trimetazidine combined with Shexiang-baoxin Pills on plasma BNP level and serum hs-CRP level of aged patients with heart failure caused by ischemic cardiomyopathy","volume":"24","author":"Fang","year":"2016","journal-title":"Pract J Card Cereb Pneumal Vasc Dis"},{"key":"R29-20230914","first-page":"196","article-title":"Efficacy of Shexiang Baoxin Pills combined with trimetazidine in senile ischemic cardiomyopathy heart failure","volume":"4","author":"Sun","year":"2016","journal-title":"Cardiovasc Dis J Integra Trad Chin Western Med"},{"key":"R30-20230914","first-page":"12","article-title":"Effect of trimetazidine combined with Shexiang Baoxin Pill on 42 cases of senile patients with ischemic cardiomyopathy heart failure","volume":"2","author":"Gao","year":"2017","journal-title":"Clin Res Pract"},{"key":"R31-20230914","first-page":"105","article-title":"Clinical efficacy of Shexiang Baoxin Pill combined with trimetazidine in senile patients with heart failure caused by ischemic cardiomyopathy","volume":"15","author":"Guo","year":"2017","journal-title":"J China Prescrip Drug"},{"key":"R32-20230914","first-page":"58","article-title":"Analysis of Shexiang Baoxin Pill combined with trimetazidine on clinical efficacy in senile patients with heart failure caused by ischemic cardiomyopathy","volume":"17","author":"Wang","year":"2017","journal-title":"World Latest Med Inform"},{"key":"R33-20230914","first-page":"125","article-title":"Analysis of curative effect of heart pill of musk and trimetazidine in senile patients with ischemic cardiomyopathy heart failure","volume":"36","author":"Zhang","year":"2017","journal-title":"China Foreign Med Treat"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/164_2016_74","article-title":"Epidemiology of heart failure","volume":"243","author":"Orso","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"R36-20230914","first-page":"1065","article-title":"Clinical controlled study on danhong injection in the treatment to acute heart failure caused by ischemic cardiomyopathy","volume":"12","author":"Chen","year":"2017","journal-title":"World Chin Med"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","article-title":"EUR observational research programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/164_2017_24","article-title":"Heart failure guidelines on pharmacotherapy","volume":"243","author":"Papadimitriou","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"R39-20230914","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1253\/circj.CJ-16-0216","article-title":"Prognostic impact of loop diuretics in patients with chronic heart failure - effects of addition of renin-angiotensin-aldosterone system inhibitors and \u03b2-blockers","volume":"80","author":"Miura","year":"2016","journal-title":"Circ J"},{"key":"R40-20230914","first-page":"305","article-title":"Potential benefits of Chinese Herbal Medicine for elderly patients with cardiovascular diseases","volume":"10","author":"Luo","year":"2013","journal-title":"J Geriatr Cardiol"},{"key":"R41-20230914","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2016.03.514","article-title":"Impact of ejection fraction and aortic valve gradient on outcomes of transcatheter aortic valve replacement","volume":"67","author":"Suzanne","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R42-20230914","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.4314\/tjpr.v16i8.35","article-title":"Atorvastatin\/trimetazidine combination therapy in patients with chronic cardiac failure","volume":"16","author":"Xu","year":"2017","journal-title":"Trop J Pharma Res"},{"key":"R43-20230914","first-page":"88","article-title":"Impact of trimetazidine combined with Shexiang\u2014baoxin pills on plasma BNP level and serum hs-CRP level of aged patients with heart failure caused by ischemic cardiomyopathy","volume":"24","author":"Fang","year":"2016","journal-title":"Pract J Card Cereb Pneumal Vascu Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201812210-00039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:53:13Z","timestamp":1694724793000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201812210-00039"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":42,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013580","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}